BioTime to Present at the LD Micro 11th Annual Main Event Investor Conference on December 5th, 2018
November 29 2018 - 8:00AM
Business Wire
BioTime, Inc. (NYSE American: BTX), a clinical-stage
biotechnology company focused on degenerative diseases, today
announced that Brian M. Culley, Chief Executive Officer of BioTime
will be presenting at the LD Micro 11th Annual Main Event Investor
Conference on December 5th, 2018 at 8am Pacific Time at the Luxe
Sunset Boulevard Hotel in Los Angeles, CA.
Interested parties can access a live audio webcast on the Events
and Presentations section of BioTime’s website. An archived
presentation will be available on the website for 30 days.
Conference updates can be found on the LD Micro website and
directly via Twitter (@theLDMicro).
About BioTime, Inc.
BioTime is a clinical-stage biotechnology company focused
on the development and commercialization of novel therapies for the
treatment of degenerative diseases. BioTime’s pipeline is based on
two platform technologies which encompass cell replacement and
cell/drug delivery. BioTime’s lead cell replacement product
candidate is OpRegen®, a retinal pigment epithelium transplant
therapy in Phase 2 development for the treatment of dry age-related
macular degeneration, the leading cause of blindness in the
developed world. BioTime’s lead cell delivery clinical program is
Renevia®, an investigational medical device being developed as an
alternative for whole adipose tissue transfer procedures.
BioTime common stock is traded on the NYSE American and TASE
under the symbol BTX. For more information, please
visit www.biotime.com or connect with the company on
Twitter, LinkedIn, Facebook, YouTube, and Google+. To
receive ongoing BioTime corporate communications, please
click on the following link to join the Company’s email alert
list: http://news.biotime.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181129005108/en/
BioTime Inc. IRIoana C. Hone(ir@biotimeinc.com)(510)
871-4188
Solebury Trout IRGitanjali Jain
Ogawa(Gogawa@troutgroup.com)(646) 378-2949
Brooklyn ImmunoTherapeut... (AMEX:BTX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Brooklyn ImmunoTherapeut... (AMEX:BTX)
Historical Stock Chart
From Jul 2023 to Jul 2024